Brazilian pharmaceutical distributor chooses software from IBS

Brazilian pharmaceutical distributor chooses software from IBS IBS has signed a new contract for IBS Pharma, IBS' market-leading supply chain management and distribution software for pharmaceutical wholesalers. The contract was signed with Audifar in Brazil. Audifar, with a revenue of USD 200m, is one of the leading and fastest growing pharmaceutical wholesalers in the Sao Paolo region. Last year, Audifar almost doubled its revenue through acquisitions. The new software will help Audifar handle customer relations, manage growth and integrate their business processes. - Today we are using different systems for the business operations at our different locations, as well as for our financial control and reporting, says Elizeu Bueno, CEO of Audifar. With the new IBS software we will achieve an effective operations control, reducing costs and increasing our performance as a distributor of pharmaceutical products. - We found in IBS the best partnership to support and develop our business with security, commitment, functionality and lower costs, says Celso Pereira, Financial Manager of Audifar. IBS Pharma is based on IBS´ ASW business software and consists of components for supply chain automation, warehouse and inventory management, logistics planning, sales call planning, customer relations management, finance management, business analysis and e-commerce. The solution can process more than 2 million orders per hour in a productive environment. It speeds up sales and purchase processing, optimises stock, minimises errors and out-of-stock situations, and enhances logistics planning. - This order shows that we have a very competitive solution for pharmaceutical wholesalers also for the Brazilian and Latin American market, says Alberto Milheiro, MD, IBS Brazil. - This market sector, with very challenging demands on its software solutions, is very interesting for IBS, says Magnus Wastenson, VP Global Marketing for the IBS Group. We see a huge global potential and growth opportunity for IBS Pharma. For information please contact: Staffan Ahlberg, CEO, IBS AB Magnus Wastenson, VP Global Tel: +46 (0)8 6272420, +46 Marketing, IBS AB (0)70 6272420 Tel: +46 (0)8 6272515, +46 email: staffan.ahlberg@ibs.se (0)70 6272515 email: magnus.wastenson@ibs.se Björn Bontin, CFO, IBS AB Tel. +46 (0)8 6272402, +46 (0)70 6272402 email: bjorn.bontin@ibs.se IBS, International Business Systems, is a leading global provider of integrated supply chain execution and customer relation solutions for distributors and demand-driven international manufacturing companies. IBS' primary focus is mid-sized and large wholesale distributors as well as sales and manufacturing companies in international groups, especially in pharmaceuticals, electronic parts and equipment, automotive parts and supplies, machinery, industrial supplies and consumer durables. IBS is recognised by AMR Research as a leading supplier of supply chain execution software and services. IBS has some 5,000 customers, among them many leading companies like Volvo, Miele, Nautor Swan, Galexis, Ciba Vision, Maxell, ABB, Expert, Cartier and Lear Corporation. The IBS Group has revenues of $260m, 2,250 employeesand permanent operations in 22 countries. IBS is listed on the Stockholm Stock Exchange ("IBS B"). For more information, please visit www.ibs.se ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2002/04/12/20020412BIT00350/wkr0001.doc http://www.waymaker.net/bitonline/2002/04/12/20020412BIT00350/wkr0002.pdf